Dokter Tom Eyckmans
ActiveDokter Tom Eyckmans has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €266k and a net result of €145k. Equity is growing by ~33.6% per year across the filed fiscal years. Its solvency ranks better than 76% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
94
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 6.27 against 13.04 in 2024; short-term debt: 14.7% and cash: 26.7% of total assets), and 15% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
85%
Return on assets
46.4%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-05-2026, 70 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
70 d early
2024
22 d early
2023
37 d early
2022
27 d early
2021
48 d early
2020
11 d late
2019
14 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€266k▼ 11.5%
2024 · €301k
2019: €45k
2020: €94k
2021: €402k
2022: €19k
2023: €137k
2024: €301k
2019 → 2025
Total assets
€314k▼ 5.0%
2024 · €330k
2019: €48k
2020: €104k
2021: €459k
2022: €335k
2023: €365k
2024: €330k
2019 → 2025
Net result
€145k▼ 11.1%
2024 · €164k
2019: €33k
2020: €49k
2021: €308k
2022: €258k
2023: €295k
2024: €164k
2019 → 2025
Working capital
€243k▼ 13.5%
2024 · €281k
2019: €45k
2020: €93k
2021: €391k
2022: €9k
2023: €116k
2024: €281k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€402k-€19k▼ 95.4%€137k▲ 639%€301k▲ 119%€266k▼ 11.5%
Operating result€406k-€339k▼ 16.4%€388k▲ 14.6%€212k▼ 45.4%€196k▼ 7.8%
Net result€308k-€258k▼ 16.4%€295k▲ 14.6%€164k▼ 44.6%€145k▼ 11.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 8% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €314k
Fixed assets
€24k▼ 4.9%
Current assets
€289k▼ 5.0%
Equity and liabilities €314k
Equity
€266k▼ 11.5%
Debt
€47k▲ 62.6%
The debt ratio rises from 8.8% to 15.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€207k▼
2024 · €222k
Cash flow
€157k▼
2024 · €174k
Solvency
85.0%▼
2024 · 91.2%
Current ratio
6.27▼
2024 · 13.04
Quick ratio
6.27▼
2024 · 13.04
Debt / equity
0.18▲
2024 · 0.10
ROE
54.6%▲
2024 · 54.3%
ROA
46.4%▼
2024 · 49.6%
Interest coverage
72.15▼
2024 · 133.89
Debt
€47k▲
2024 · €29k
Debt ≤ 1 year
€46k▲
2024 · €23k
Debt > 1 year
€0▼
2024 · €5k
Income taxes
€54k▲
2024 · €49k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€330k€314k▼
Fixed assets21/28€26k€24k▼
Tangible fixed assets22/27€26k€24k▼
Furniture and vehicles24€865€7k▲
Leasing and similar rights25€13k€4k▼
Other tangible fixed assets26€12k€13k▲
Current assets29/58€304k€289k▼
Amounts receivable within one year40/41€3k€0▼
Trade receivables40€600€0▼
Other amounts receivable41€3k€0▼
Current investments50/53€74k€129k▲
Cash at bank and in hand54/58€184k€84k▼
Deferred charges and accrued income490/1€44k€77k▲
Equity and liabilities
Total equity and liabilities10/49€330k€314k▼
Equity10/15€301k€266k▼
Contributions10/11€19k€19k=
Reserves13-€91k
Distributable reserves133-€91k
Profit (loss) carried forward14€282k€157k▼
Amounts payable17/49€29k€47k▲
Amounts payable after more than one year17€5k€0▼
Financial debts170/4€5k€0▼
Amounts payable within one year42/48€23k€46k▲
Current portion of amounts payable after more than one year42€8k€4k▼
Financial debts43-€10k
Credit institutions430/8-€10k
Trade debts44€1k€3k▲
Suppliers440/4€1k€3k▲
Taxes, remuneration and social security45€8k€22k▲
Taxes450/3€8k€22k▲
Other amounts payable47/48€6k€7k▲
Accrued charges and deferred income492/3€608€930▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€11k▲
Other operating charges640/8€3k€3k▲
Gross operating margin9900€225k€210k▼
Operating profit (loss)9901€212k€196k▼
Financial income75/76B€2k€7k▲
Recurring financial income75€2k€7k▲
Financial charges65/66B€2k€3k▲
Recurring financial charges65€2k€3k▲
Profit (loss) for the period before taxes9903€212k€200k▼
Income taxes67/77€49k€54k▲
Profit (loss) for the period9904€164k€145k▼
Profit (loss) for the period to be appropriated9905€164k€145k▼
Appropriation of the result
Profit (loss) to be appropriated9906€282k€428k▲
Profit (loss) brought forward from the previous period14P€119k€282k▲
Transfer to equity691/2-€91k
To other reserves6921-€91k
Profit to be distributed694/7€0€180k▲
Return on contributions (dividend)694€0€180k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
09-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity times 8current ratio 13.04
Current ratio from 1.54 to 13.04; short-term debt falls from €214k to €23k.
31-12
Financial
Equity above €200kEq €301k ▲119%
6 profitable years in a row build equity to €301k.
24-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €100kEq €137k ▲639%
5 profitable years in a row build equity to €137k.
04-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
13-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Highest result since 2019net €308k ▲528%
Operating result €406k, net result €308k, both a record.
31-12
Financial
Equity above €200kEq €402k ▲326%
3 profitable years in a row build equity to €402k.
11-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 11 days late
2020
14-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 14 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mechelen · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zilverberklaan(MZN) 12A2812 MechelenGround area
1,752 m²
Building footprint
257 m²
Volume, LiDAR
1,202 m³
2 parcels, Flanders · tallest building 15.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dokter Tom Eyckmans
since 20182.278.775.468
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12409C0082/00V000 | Flanders | 890 m² | 1 · 107 m² | 7.4 m · 2 fl. |
| 12409C0082/00T000 | Flanders | 862 m² | 1 · 150 m² | 15.1 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
64888G2DLD66Q8W56N05
Similar companies · same sector, comparable size
JV Endocrino
BE 0788.332.163
Waregem · Eq €266k
Dr JC DONNAY Anesthésie Réanimation
BE 0890.267.285
Neufchâteau · Eq €266k
RESPIR-WAL
BE 0757.766.572
Saint-Ghislain · Eq €266k
Dr. Johan Helderweirt, anesthesist
BE 0508.675.918
Leuven · Eq €266k
Dokter Sofie Geth
BE 0716.798.524
Schoten · Eq €266k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 6,677 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-08-2018
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
72109Other research and development on natural sciences
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
85599Other education
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.